Announcements Trials
Browse Landscape

Status

Completed 6Unknown 3Terminated 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 98Observational 3

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 3

Interventions

Blood Specimen Collection 85Surveys and Questionnaires 83Surgical Procedures, Operative 44Drug Therapy 32Radiotherapy 27Biopsy 26Amplified Fragment Length Polymorphism Analysis 24Neoadjuvant Therapy 23Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Data Collection 18Immunotherapy 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Magnetic Resonance Spectroscopy 16Liquid Biopsy 16pembrolizumab 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Observation 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 13Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Observational × Temozolomide × Clear all
NCT03567135 2020-03-03

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Fuzhou General Hospital

Unknown
60 enrolled
CNS

Glioblastoma

NCT03631823 2018-08-15

Gut Microbiota and Glioblastoma Multiforme Prognosis

Huashan Hospital

Unknown
200 enrolled
CNS

Glioblastoma

NCT03225963 2017-07-24

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Taichung Veterans General Hospital

Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡